(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OXIBLUME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OXIBLUME

ST13

US500000079414149

Class

5

Filing

79414149

Registration

8208692

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

07/14/2026

Trademark type

Combined

Nice classes

5

Filing date

06/14/2024

Registration date

04/14/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/14/2026

Last transaction

07/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

16

Owner location

IT

Examiner

FLETCHER, TRACY L

Law office

M60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "OXIBLUME".

Holders and representatives

Holders

FUTURA S.R.L.

Representatives

Theodore R. Remaklus Thompson Hine LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalsnamely anti-inflammatories; medical preparationsnamely anti-inflammatories; sanitary preparations for medical purposes; dietetic food and beverages for medical and veterinary use; food for babies; dietary supplements for humans and animals; disinfectants; dietary supplements; nutritional food additives for medical purposes in the nature of natural food extracts derived from gastrodin; dietetic foods for medical purposes; dietetic beverages for medical purposes; dietary supplements for humans not for medical purposes; vitamin supplements; nutritional supplements; protein dietary supplements; vitamin and mineral supplements; probiotic supplements; anti-oxidant vitamin supplements; anti-inflammatory preparations; prebiotic supplements; mineral dietary supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment of inflammatory conditions; nutraceuticals for use as a dietary supplement; phytotherapy preparations for medical purposes; herbal extractsother than essential oilsfor medical use; extracts of medicinal plants and herbsother than essential oilsfor medical use; plant extractsother than essential oilsfor pharmaceutical purposes; dietary vegetable fiber for use as a dietary supplement; vitamins; milk ferments for pharmaceutical purposes; cultures of microorganisms for medical or veterinary use for use in dietary supplements; cultures of microorganisms for medical and veterinary uses; antimicrobial preparations for inhibiting bacteria; bacterial preparations for medical or veterinary purposes; biological preparations for medical and veterinary purposes for the prevention and treatment of inflammatory conditions; preparations of microorganisms for medical or veterinary use; medical preparations for personal hygiene or for sanitary use being sanitary sterilizing preparations.

Publications

History of USPTO decisions and trademark events.

23 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/14/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/18/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/01/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/31/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/14/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/24/2026

PUBO

PUBLISHED FOR OPPOSITION

02/24/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/18/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/30/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/30/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/30/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/30/2026

RFNT

REFUSAL PROCESSED BY IB

11/15/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/28/2025

RFRR

REFUSAL PROCESSED BY MPU

10/28/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/10/2025

CNRT

NON-FINAL ACTION WRITTEN

09/09/2025

DOCK

ASSIGNED TO EXAMINER

09/06/2025

MAFR

APPLICATION FILING RECEIPT MAILED

09/05/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/05/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/18/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/02/2025

Continuous trademark protection

Get notified about every new filing that threatens OXIBLUME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.